Skip to search formSkip to main contentSkip to account menu

cetuximab

Known as: Cetuximab [Chemical/Ingredient], Anti-EGFR Monoclonal Antibody, Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 
A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the… 
National Institutes of Health

Related topics

Related topics

17 relations
100 ML cetuximab 2 MG/ML Injection50 ML cetuximab 2 MG/ML Injection [Erbitux]Antibody-Dependent Cellular CytotoxicityCisplatin-Cetuximab Regimen

Broader (1)

Antineoplastic Agents

Narrower (2)

ErbituxIMC C225

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Promising systemic immunotherapies in head and neck squamous cell carcinoma.
Highly Cited
2013
Highly Cited
2013
Promotion of neuronal differentiation of neural progenitor cells by using EGFR antibody functionalized collagen scaffolds for spinal cord injury repair.
Highly Cited
2013
Highly Cited
2013
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
The European Medicines Agency received recently the first marketing authorization application for a biosimilar monoclonal… 
Highly Cited
2011
Highly Cited
2011
Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.
Highly Cited
2011
Highly Cited
2011
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).
5500 Background: The concurrent use of cisplatin (CDDP) or cetuximab (CET) with radiation (RT) has been shown to improve survival… 
Highly Cited
2010
Highly Cited
2010
KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
BackgroundObservational studies of patients with primary colorectal cancer have identified KRAS mutation as a marker of poor… 
Highly Cited
2008
Highly Cited
2008
Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection.
Review
2003
Review
2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
PURPOSE Targeted systemic radiation therapy using radiolabeled antibodies results in tumor doses sufficient to produce… 
Highly Cited
2000
Highly Cited
2000
Epidermal growth factor receptor blockade by antibody IMC‐C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice
Pancreatic carcinoma is associated with a poor prognosis, and treatment options for patients with this disease are limited. The… 
Highly Cited
1959
Highly Cited
1959
New method of solution for unretarded satellite orbits
An axially symmetric solution of Laplace's equation in oblate spher oidal coordin ates is found, which may be used as t he… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)